首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Ejhaem

缩写:

ISSN:2688-6146

e-ISSN:2688-6146

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1401条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
George John,Sumeet Mirgh,Sachin Punatar et al. George John et al.
Background: Multiple myeloma (MM) is primarily a disease of the elderly; data on young patients are limited. Aim: To evaluate the clini...
Michelle A E Brouwer,Arie Arensman,H Rob Taal et al. Michelle A E Brouwer et al.
Introduction: Specific granule deficiency type II (SGD2) is a rare heterogeneous congenital disease characterized by early-onset life-threatening infections. SGD2 is caused by autosomal recessive mutations in the SMARCD2 ...
Matthias Bleeke,Claudia Niekrens,Soumya Datta et al. Matthias Bleeke et al.
Introduction: Treatment with luspatercept may improve transfusion requirements in transfusion-dependent thalassemia (TDT), but the improved erythroid maturation in the bone marrow influences body iron distribution. ...
Ukyo Kondo,Taku Kikuchi,Shotaro Sugita et al. Ukyo Kondo et al.
Background: The cumulative incidence and risk of cytomegalovirus (CMV) reactivation in patients with relapsed/refractory multiple myeloma (RRMM) receiving elranatamab remain unclear. ...
Mostafa F Mohammed Saleh,Abdulrahman Nasiri,Ahmed Alahmadi et al. Mostafa F Mohammed Saleh et al.
Chimeric antigen receptor (CAR) T-cell therapy is a highly effective treatment for relapsed or refractory large B-cell lymphoma (LBCL), but clinical experience in people living with HIV (PLWH) remains limited due to their exclusion from piv...
Mahsa Khanlari,Wei Wang,Paul E Mead et al. Mahsa Khanlari et al.
Background: Expression of B-cell antigens is rare in T-lymphoblastic leukemia/lymphoma (T-LBLL), and the significance is uncertain. Objective and methods:...
Gerasimos Tsilimidos,Filipe Martins,Mariangela Costanza et al. Gerasimos Tsilimidos et al.
Introduction: 5-Azacitidine (AZA) is a major treatment option for myelodysplastic neoplasms (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN). Here we evaluate the efficacy and toxicity of an alternative AZ...
Yoshikazu Ikoma,Yuto Kaneda,Ryoma Shimazu et al. Yoshikazu Ikoma et al.
Background: Epcoritamab, a bispecific CD3×CD20 antibody, offers a promising treatment for relapsed diffuse large B-cell lymphoma (DLBCL). Its efficacy and safety after allogeneic hematopoietic stem cell transplantation (...